Industry proponents say continuous manufacturing produces better quality pharmaceutical products and at lower cost than those produced by batch processes. Sell the economic benefits to upper management, they say, and don’t be discouraged by the higher initial costs and perceived regulatory roadblocks.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?